Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(36%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
36%
Ph phase_1
2
18%
Ph not_applicable
2
18%
Ph phase_3
2
18%

Phase Distribution

2

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting2
unknown2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (20.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)
N/A2 (20.0%)

Trials by Status

recruiting218%
completed545%
unknown218%
active_not_recruiting218%

Recent Activity

4 active trials
Showing 5 of 11
recruitingnot_applicable

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

NCT07493421
recruitingphase_3

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

NCT05871099
active_not_recruiting

Effects of HIPEC on Postoperative Bowel Motility and Complications

NCT07353177
active_not_recruitingphase_3

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

NCT03348150
completedphase_1

Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

NCT02672098
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07493421Not Applicable

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Recruiting
NCT05871099Phase 3

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Recruiting
NCT07353177

Effects of HIPEC on Postoperative Bowel Motility and Complications

Active Not Recruiting
NCT03348150Phase 3

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

Active Not Recruiting
NCT02672098Phase 1

Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

Completed
NCT02249013Phase 2

Short-course HIPEC in Advanced Epithelial Ovarian Cancer

Completed
NCT04345770Phase 2

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

Unknown
NCT02528110Phase 2

Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

Completed
NCT02830139Phase 2

Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer

Completed
NCT02672865Phase 1

Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer

Completed
NCT01539785Not Applicable

Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

Unknown

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11